TrialJAMA network open2021

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.

Timo Vesikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.